[382] Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study

Duc Binh Phan; Hugo Jourdain; Miguel Angel Descalzo-Gallego; Mahmoud Zureik; Alicia González-Quesada; Raquel Rivera-Díaz; Antonio Sahuquillo-Torralba; Mark Lunt; Ignacio Garcia-Doval; Emilie Sbidian; Richard B Warren; Zenas Zee Ngai Yiu

doi:10.1002/pds.5891

[382] Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study

Duc Binh Phan, Hugo Jourdain, Miguel Angel Descalzo-Gallego, Mahmoud Zureik, Alicia González-Quesada, Raquel Rivera-Díaz, Antonio Sahuquillo-Torralba, Mark Lunt, Ignacio Garcia-Doval, Emilie Sbidian, Richard B Warren, Zenas Zee Ngai Yiu

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	Pharmacoepidemiology and Drug Safety
DOIs	https://doi.org/10.1002/pds.5891
Publication status	Published - 19 Nov 2024

Access to Document

10.1002/pds.5891

Cite this

Phan, D. B., Jourdain, H., Descalzo-Gallego, M. A., Zureik, M., González-Quesada, A., Rivera-Díaz, R., Sahuquillo-Torralba, A., Lunt, M., Garcia-Doval, I., Sbidian, E., Warren, R. B., & Yiu, Z. Z. N. (2024). [382] Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5891

@article{b168f94cb2a54757ac262ada64edec08,

title = "[382] Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study",

author = "Phan, {Duc Binh} and Hugo Jourdain and Descalzo-Gallego, {Miguel Angel} and Mahmoud Zureik and Alicia Gonz{\'a}lez-Quesada and Raquel Rivera-D{\'i}az and Antonio Sahuquillo-Torralba and Mark Lunt and Ignacio Garcia-Doval and Emilie Sbidian and Warren, {Richard B} and Yiu, {Zenas Zee Ngai}",

year = "2024",

month = nov,

day = "19",

doi = "10.1002/pds.5891",

language = "English",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John Wiley & Sons Ltd",

}

Phan, DB, Jourdain, H, Descalzo-Gallego, MA, Zureik, M, González-Quesada, A, Rivera-Díaz, R, Sahuquillo-Torralba, A, Lunt, M, Garcia-Doval, I, Sbidian, E, Warren, RB & Yiu, ZZN 2024, '[382] Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study', Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5891

TY - JOUR

T1 - [382] Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study

AU - Phan, Duc Binh

AU - Jourdain, Hugo

AU - Descalzo-Gallego, Miguel Angel

AU - Zureik, Mahmoud

AU - González-Quesada, Alicia

AU - Rivera-Díaz, Raquel

AU - Sahuquillo-Torralba, Antonio

AU - Lunt, Mark

AU - Garcia-Doval, Ignacio

AU - Sbidian, Emilie

AU - Warren, Richard B

AU - Yiu, Zenas Zee Ngai

PY - 2024/11/19

Y1 - 2024/11/19

U2 - 10.1002/pds.5891

DO - 10.1002/pds.5891

M3 - Meeting Abstract

SN - 1053-8569

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

ER -